Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

GRF-induced GH response in attention-deficit hyperactivity disorder.

R Cacabelos1, M Albarrán, C Diéguez

  • 1Department of Human Physiology, Complutense University Medical School, Madrid, Spain.

Methods and Findings in Experimental and Clinical Pharmacology
|January 1, 1990
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A phase 2 randomized controlled trial using biologics to improve multi OIT outcomes (COMBINE): design, rationale, and methods.

Frontiers in allergy·2026
Same author

The effects of ghrelin and LEAP-2 in energy homeostasis are modulated by thermoneutrality, high-fat diet and aging.

Journal of endocrinological investigation·2024
Same author

Associations of accumulated persistent organic pollutants in breast adipose tissue with the evolution of breast cancer after surgery.

The Science of the total environment·2023
Same author

AMP-activated protein kinase (AMPK) signaling in GnRH neurons links energy status and reproduction.

Metabolism: clinical and experimental·2020
Same author

Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2020
Same author

Role of leptin and ghrelin in the regulation of gonadal function.

Expert review of endocrinology & metabolism·2019

Growth hormone (GH) response to growth-releasing factor (GRF) was studied in children with attention-deficit hyperactivity disorder (ADHD). ADHD patients showed altered GH response patterns, suggesting potential diagnostic and therapeutic insights.

Area of Science:

  • Neuroendocrinology
  • Child Psychiatry
  • Behavioral Science

Background:

  • Attention-deficit hyperactivity disorder (ADHD) is a common disruptive behavior disorder in children with unknown causes.
  • The growth hormone-releasing hormone-somatostatin-growth hormone (GRF-SS-GH) axis is a key neuroendocrine pathway.
  • Previous studies suggest altered neuroendocrine function in some mental disorders.

Purpose of the Study:

  • To investigate the growth hormone (GH) response to exogenous GRF administration in children with ADHD.
  • To evaluate the functioning of the somatotropinergic system (GRF-SS-GH-SM axis) in ADHD.
  • To explore the potential of this neuroendocrine test as a diagnostic marker or therapeutic predictor for ADHD.

Main Methods:

  • A controlled study involving 12 children with ADHD and 6 healthy children (ages 7-9).

Related Experiment Videos

  • Intravenous administration of 150 micrograms of GRF (1-29) NH2.
  • Measurement of serum GH levels at baseline and at intervals up to 120 minutes post-injection.

    • Main Results:

    • Healthy children showed a peak GH response 15 minutes after GRF injection.
    • ADHD children exhibited a blunted initial GH response, with a plateau from 15 to 60 minutes.
    • Significantly higher serum GH levels were observed in ADHD patients at 90 and 120 minutes compared to controls.
    • Two distinct subgroups of ADHD patients were identified based on GRF-induced GH response: one with high GH response and another with hyporeactive GH.

    Conclusions:

    • The GRF-induced GH response differs between children with ADHD and healthy controls.
    • The somatotropinergic system may be dysregulated in ADHD, presenting as distinct response patterns.
    • This neuroendocrine test shows potential as a diagnostic tool and/or therapeutic predictor in ADHD management.